FDMT - 4D Molecular Therapeutics, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 9.84

Open

$ 9.95

Bid

$ 9.92 x 20

Ask

$ 10.70 x 10

Day's Range

$ 9.61 - $ 10.25

52 Week Range

$ 2.24 - $ 10.73

Volume

470,447

Average Volume

Market Cap

551.9M

Beta (5Y Monthly)

$ 1.62

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-28-2025	01-01-1970	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-15-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-28-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-25-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

On Sept 30, 4d Molecular Therapeutics Appo...
10/02/2025 20:12:01

-SEC Filing

12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

jim-cramer-applovin-calls-for-prudence-this-health-care-stock-is-pure-spec

Jim Cramer: AppLovin Calls For Prudence, T...
09/03/2025 11:46:59

Jim Cramer doesn't recommend buying more AppLovin stock. "Let's take a little off the table just to be prudent,"...

4D Molecular Therapeutics Says 4FRONT-1 Ph...
09/02/2025 12:14:19

What 4 Analyst Ratings Have To Say About 4...
08/12/2025 19:01:25

Roth Capital Maintains Buy on 4D Molecular...
08/12/2025 17:49:17

Roth Capital analyst Salveen Richter maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and lowers the price targe...

Chardan Capital Maintains Buy on 4D Molecu...
08/12/2025 10:49:51

Chardan Capital analyst Geulah Livshits maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and maintains $25 price...

4D Molecular Therapeutics Q2 EPS $(0.98) M...
08/11/2025 12:17:31

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.98) per share which missed the analyst consensus estim...

12 Health Care Stocks Moving In Monday's I...
08/04/2025 17:06:36

Assessing 4D Molecular Therapeutics: Insig...
08/01/2025 22:04:04

4d-molecular-therapeutics-rallies-on-heels-of-diabetes-related-vision-study

4D Molecular Therapeutics Rallies On Heels...
08/01/2025 14:29:21

4D Molecular's 4D-150 showed sustained vision and anatomical improvements with fewer injections in DME, supported by regula...

12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

Market-Moving News for August 1st
08/01/2025 11:15:14

FIG: 28% | Figma shares are trading higher on momentum following Thursday's IPO. COIN: -11% | Coinbase shares are trading l...

why-apple-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Why Apple Shares Are Trading Higher; Here ...
08/01/2025 10:56:59

12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

4DMT Presents Results Of 4D-150 SPECTRA Cl...
07/31/2025 20:25:24

4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level4D-150 demonstrat...

What 4 Analyst Ratings Have To Say About 4...
07/03/2025 19:01:16

Chardan Capital Maintains Buy on 4D Molecu...
07/03/2025 12:05:08

Chardan Capital analyst Geulah Livshits maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and maintains $25 price...

4D Molecular Therapeutics Cuts Workforce B...
07/02/2025 20:22:35

Implemented a workforce reduction of approximately 25% of current and planned roles in July 2025, primarily in the areas suppor...